Literature DB >> 12412577

Managing cutaneous reactions to imatinib therapy.

Simon A J Rule, Stephen G O'Brien, Lucy C Crossman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12412577     DOI: 10.1182/blood-2002-08-2431

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  16 in total

Review 1.  New agents, new rashes: an update on skin complications from cancer chemotherapy.

Authors:  Smitha Patiyil; S Ni Chan; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

2.  Serious skin reaction associated with imatinib in a patient with chronic myeloid leukemia.

Authors:  Murat Albayrak; Harika Celebi; Aynur Albayrak; Esra Saribacak Can; Vedat Aslan; Birgul Onec; Ipek Coban
Journal:  Eurasian J Med       Date:  2011-12

3.  Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor.

Authors:  Jun-Eul Hwang; Ju-Young Yoon; Woo-Kyun Bae; Hyun-Jeong Shim; Sang-Hee Cho; Ik-Joo Chung
Journal:  BMC Cancer       Date:  2010-08-18       Impact factor: 4.430

4.  Imatinib-induced Stevens-Johnsons syndrome.

Authors:  Praveen Jha; D Himanshu; Nirdesh Jain; Ajay Kumar Singh
Journal:  BMJ Case Rep       Date:  2013-01-23

5.  Life-threatening dermatologic adverse events in oncology.

Authors:  Alyx C Rosen; Yevgeniy Balagula; Dennis W Raisch; Vishvas Garg; Beatrice Nardone; Nicole Larsen; Jennifer Sorrell; Dennis P West; Milan J Anadkat; Mario E Lacouture
Journal:  Anticancer Drugs       Date:  2014-02       Impact factor: 2.248

Review 6.  Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).

Authors:  Emily L Coleman; Brianna Olamiju; Jonathan S Leventhal
Journal:  Oncol Rep       Date:  2020-12-24       Impact factor: 3.906

7.  Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.

Authors:  Tariq I Mughal; Andrew Schrieber
Journal:  Biologics       Date:  2010-12-02

8.  Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™).

Authors:  Ah Young Cho; Dae Hun Kim; Myung Im; Young Lee; Young Joon Seo; Jeung Hoon Lee
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

9.  Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors.

Authors:  Xuan Huang; Samir Patel; Nasir Ahmed; Karen Seiter; Delong Liu
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Authors:  Martin Henkes; Heiko van der Kuip; Walter E Aulitzky
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.